|
Gland Pharma Ltd.
|
Ratio Analysis
|
|
|
You can view the
Ratio Analysis
for the last 5 years.
|
Market Cap. (Rs.)
|
27637.89 Cr.
|
P/BV
|
2.81
|
Book Value (Rs.)
|
596.28
|
|
52 Week High/Low (Rs.)
|
2131/1278
|
FV/ML
|
1/1
|
P/E(X)
|
39.57
|
|
Bookclosure
|
14/08/2025
|
EPS (Rs.)
|
42.40
|
Div Yield (%)
|
0.00
|
|
| Months | 12 | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR | AR | AR |
| FaceValue | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| | | | | | |
| PER SHARE RATIOS | | | | | |
| | | | | | |
| Basic EPS (Rs.) | 42.40 | 46.90 | 47.44 | 73.81 | 63.07 |
| Diluted EPS (Rs.) | 42.40 | 46.90 | 47.43 | 73.81 | 62.99 |
| Cash EPS (Rs.) | 65.33 | 67.82 | 56.33 | 80.46 | 66.98 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 555.40 | 529.65 | 483.23 | 435.64 | 360.86 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 555.40 | 529.65 | 483.23 | 435.64 | 360.86 |
| Revenue From Operations / Share (Rs.) | 340.89 | 343.92 | 220.07 | 267.85 | 211.68 |
| PBDIT / Share (Rs.) | 89.98 | 91.27 | 76.82 | 105.54 | 87.84 |
| PBIT / Share (Rs.) | 67.05 | 70.35 | 67.91 | 98.83 | 81.80 |
| PBT / Share (Rs.) | 64.50 | 68.76 | 64.03 | 98.51 | 81.59 |
| Net Profit / Share (Rs.) | 42.40 | 46.90 | 47.42 | 73.75 | 60.94 |
| NP After MI And SOA / Share (Rs.) | 42.40 | 46.90 | 47.42 | 73.75 | 60.94 |
| | | | | | |
| PROFITABILITY RATIOS | | | | | |
| | | | | | |
| PBDIT Margin (%) | 26.39 | 26.53 | 34.90 | 39.40 | 41.49 |
| PBIT Margin (%) | 19.66 | 20.45 | 30.85 | 36.89 | 38.64 |
| PBT Margin (%) | 18.92 | 19.99 | 29.09 | 36.77 | 38.54 |
| Net Profit Margin (%) | 12.43 | 13.63 | 21.54 | 27.53 | 28.79 |
| NP After MI And SOA Margin (%) | 12.43 | 13.63 | 21.54 | 27.53 | 28.79 |
| Return on Networth / Equity (%) | 7.63 | 8.85 | 9.81 | 16.92 | 16.88 |
| Return on Capital Employeed (%) | 11.43 | 12.50 | 13.89 | 22.39 | 22.36 |
| Return On Assets (%) | 6.22 | 7.24 | 8.89 | 15.46 | 15.34 |
| Long Term Debt / Equity (X) | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 |
| Total Debt / Equity (X) | 0.02 | 0.03 | 0.00 | 0.00 | 0.00 |
| Asset Turnover Ratio (%) | 0.51 | 0.58 | 0.43 | 0.61 | 0.65 |
| | | | | | |
| LIQUIDITY RATIOS | | | | | |
| | | | | | |
| Current Ratio (X) | 4.33 | 4.04 | 9.46 | 10.05 | 10.00 |
| Quick Ratio (X) | 3.26 | 2.85 | 6.80 | 8.02 | 7.51 |
| Inventory Turnover Ratio (X) | 3.36 | 1.25 | 1.10 | 1.66 | 1.72 |
| Dividend Payout Ratio (NP) (%) | 47.17 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend Payout Ratio (CP) (%) | 30.61 | 0.00 | 0.00 | 0.00 | 0.00 |
| Earning Retention Ratio (%) | 52.83 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Earning Retention Ratio (%) | 69.39 | 0.00 | 0.00 | 0.00 | 0.00 |
| | | | | | |
| COVERAGE RATIOS | | | | | |
| | | | | | |
| Interest Coverage Ratio (%) | 35.30 | 57.38 | 169.90 | 330.81 | 421.28 |
| Interest Coverage Ratio (Post Tax) (%) | 17.63 | 30.48 | 113.46 | 232.15 | 293.28 |
| | | | | | |
| VALUATION RATIOS | | | | | |
| | | | | | |
| Enterprise Value (Cr.) | 23946.09 | 28818.28 | 17126.99 | 50622.63 | 37532.51 |
| EV / Net Operating Revenue (X) | 4.26 | 5.09 | 4.73 | 11.50 | 10.84 |
| EV / EBITDA (X) | 16.15 | 19.17 | 13.54 | 29.19 | 26.12 |
| MarketCap / Net Operating Revenue (X) | 4.67 | 5.36 | 5.76 | 12.21 | 11.71 |
| Retention Ratios (%) | 52.82 | 0.00 | 0.00 | 0.00 | 0.00 |
| Price / BV (X) | 2.87 | 3.48 | 2.63 | 7.50 | 6.87 |
| Price / Net Operating Revenue (X) | 4.67 | 5.36 | 5.76 | 12.21 | 11.71 |
| EarningsYield | 0.02 | 0.02 | 0.03 | 0.02 | 0.02 |
